High-throughput screen for pharmacoperones of the vasopressin type 2 receptor

Journal of Biomolecular Screening

Volumn 18, Issue 8, 2013, Pages 930-937

  Conn, P Michael ^a,b   Smith, Emery ^c   Hodder, Peter ^c   Janovick, Jo Ann ^a   Smithson, David C ^b,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d Oregon Translational Research and Drug Development Institute   (United States)

Author keywords

chemical library; GPCRs; pharmacoperone; protein; vasopressin type 2 receptor (V2R)

Indexed keywords

B 7651; BREFELDIN A; F 6886; FORSKOLIN; L 2540; M 6545; MITOXANTRONE; SATAVAPTAN; UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STIMULATION;

CHEMICAL LIBRARY; GPCRS; PHARMACOPERONE; PROTEIN; VASOPRESSIN TYPE 2 RECEPTOR (V2R);

DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PROTEIN FOLDING; PROTEIN TRANSPORT; PROTEOSTASIS DEFICIENCIES; RECEPTORS, VASOPRESSIN;

EID: 84882301813     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057113483559     Document Type: Article

References (15)

1. Conn P. M., Ulloa-Aguirre A., Ito J, et al. G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue In Vivo. Pharmacol. Rev. 2007 ; 59: 225-250
2. Conn P. M., Janovick J. A.. Drug Development and the Cellular Quality Control System. Trends Pharmacol. Sci. 2009 ; 30: 228-233
3. Conn P. M., Ulloa-Aguirre A.. Trafficking of G-Protein-Coupled Receptors to the Plasma Membrane: Insights for Pharmacoperone Drugs. Trends Endocrinol. Metab. 2010 ; 21: 190-197
4. Janovick J. A., Maya-Nunez G., Conn P. M.. Rescue of Hypogonadotropic Hypogonadism-Causing and Manufactured GnRH Receptor Mutants by a Specific Protein-Folding Template: Misrouted Proteins as a Novel Disease Etiology and Therapeutic Target. J. Clin. Endocrinol. Metab. 2002 ; 87: 3255-3262
5. Castro-Fernandez C., Maya-Nunez G., Conn P. M.. Beyond the Signal Sequence: Protein Routing in Health and Disease. Endocr. Rev. 2005 ; 26: 479-503
6. Smithson D. C., Janovick J. A., Conn P. M.. Therapeutic Rescue of Misfolded/Mistrafficked Mutants: Automation-Friendly High Throughput Assays for Identification of Pharmacoperone Drugs of GPCRs. Methods Enzymol. 2013 ; 521: 3-16
7. Janovick J. A., Park B. S., Conn P. M.. Therapeutic Rescue of Misfolded Mutants: Validation of Primary High Throughput Screens for Identification of Pharmacoperone Drugs. PLoS One. 2011 ; 6: e22784
8. Hodder P., Cassaday J., Peltier R., et al. Identification of Metabotropic Glutamate Receptor Antagonists Using an Automated High-Throughput Screening System. Anal. Biochem. 2003 ; 313: 246-254
9. Morello J. P., Salahpour A., Laperriere A., et al. Pharmacological Chaperones Rescue Cell-Surface Expression and Function of Misfolded V2 Vasopressin Receptor Mutants. J. Clin. Invest. 2000 ; 105: 887-895
10. Janovick J. A., Goulet M., Bush E., et al. Structure-Activity Relations of Successful Pharmacologic Chaperones for Rescue of Naturally Occurring and Manufactured Mutants of the Gonadotropin-Releasing Hormone Receptor. J. Pharmacol. Exp. Ther. 2003 ; 305: 608-614
11. Bernier V., Morello J. P., Zarruk A., et al. Pharmacologic Chaperones as a Potential Treatment for X-linked Nephrogenic Diabetes Insipidus. J. Am. Soc. Nephrol. 2006 ; 17: 232-243
12. Kumar M., Hsiao K., Vidugiriene J., et al. A Bioluminescent-Based, HTS-Compatible Assay to Monitor G-Protein-Coupled Receptor Modulation of Cellular Cyclic AMP. Assay Drug Dev. Technol. 2007 ; 5: 237-245
13. Yokoyama K., Yamauchi A., Izumi M., et al. A Low-Affinity Vasopressin V2-Receptor Gene in a Kindred with X-Linked Nephrogenic Diabetes Insipidus. J. Am. Soc. Nephrol. 1996 ; 7: 410-414
14. Serradeil-Le Gal C.. An Overview of SR121463, a Selective Non-Peptide Vasopressin V(2) Receptor Antagonist. Cardiovasc. Drug Rev. 2001 ; 19: 201-214
15. Janovick J. A., Brothers S. P., Cornea A., et al. Refolding of Misfolded Mutant GPCR: Post-Translational Pharmacoperone Action In Vitro. Mol. Cell. Endocrinol. 2007 ; 272: 77-85